{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:41:05Z","timestamp":1792651265727,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08407-y","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T15:59:33Z","timestamp":1753286373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systemic cytokines drive conserved severity-associated myeloid responses across bacterial and viral infections"],"prefix":"10.1038","volume":"8","author":[{"given":"Kimberly","family":"Kajihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Seim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Little-Hooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Delemarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Darmanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haridha","family":"Shivram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca N.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-8822","authenticated-orcid":false,"given":"Carrie M.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-3111","authenticated-orcid":false,"given":"Sharookh B.","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0121-7397","authenticated-orcid":false,"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-0862","authenticated-orcid":false,"given":"Miguel","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"8407_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395, 200\u2013211 (2020).","journal-title":"Lancet"},{"key":"8407_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017\u20131032 (2020).","journal-title":"Nat. Med."},{"key":"8407_CR3","doi-asserted-by":"publisher","first-page":"e147610","DOI":"10.1172\/jci.insight.147610","volume":"6","author":"TE Andargie","year":"2021","unstructured":"Andargie, T. E. et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight 6, e147610 (2021).","journal-title":"JCI Insight"},{"key":"8407_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.medj.2021.01.001","volume":"2","author":"AP Cheng","year":"2021","unstructured":"Cheng, A. P. et al. Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity. Med 2, 411\u2013422.e5 (2021).","journal-title":"Med"},{"key":"8407_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46663-2","volume":"13","author":"A Charoensappakit","year":"2023","unstructured":"Charoensappakit, A. et al. Cell-free DNA as diagnostic and prognostic biomarkers for adult sepsis: a systematic review and meta-analysis. Sci. Rep. 13, 19624 (2023).","journal-title":"Sci. Rep."},{"key":"8407_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00773-0","volume":"8","author":"BA Williams","year":"2023","unstructured":"Williams, B. A., Jones, C. H., Welch, V. & True, J. M. Outlook of pandemic preparedness in a post-COVID-19 world. NPJ Vaccines 8, 178 (2023).","journal-title":"NPJ Vaccines"},{"key":"8407_CR7","doi-asserted-by":"crossref","unstructured":"Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"8407_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","volume":"22","author":"D Kumar","year":"2022","unstructured":"Kumar, D. et al. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. Lancet Infect. Dis. 22, 718\u2013730 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"8407_CR9","doi-asserted-by":"publisher","first-page":"e00352","DOI":"10.1128\/AAC.00352-20","volume":"64","author":"JJ Lim","year":"2020","unstructured":"Lim, J. J. et al. A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza A virus infection. Antimicrob. Agents Chemother. 64, e00352\u201320 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8407_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0699","author":"R Hanula","year":"2023","unstructured":"Hanula, R. et al. Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2023.0699 (2023).","journal-title":"JAMA Intern. Med."},{"key":"8407_CR11","doi-asserted-by":"publisher","first-page":"e170236","DOI":"10.1172\/JCI170236","volume":"133","author":"M Karim","year":"2023","unstructured":"Karim, M., Lo, C.-W. & Einav, S. Preparing for the next viral threat with broad-spectrum antivirals. J. Clin. Invest. 133, e170236 (2023).","journal-title":"J. Clin. Invest."},{"key":"8407_CR12","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.crphar.2021.100058","volume":"2","author":"D Tripathi","year":"2021","unstructured":"Tripathi, D., Sodani, M., Gupta, P. K. & Kulkarni, S. Host directed therapies: COVID-19 and beyond. Curr. Res. Pharmacol. Drug Discov. 2, 100058 (2021).","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"8407_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2018","unstructured":"Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S. & Bartenschlager, R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov. 17, 35\u201356 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8407_CR14","doi-asserted-by":"crossref","unstructured":"Wallis, R. S., O\u2019Garra, A., Sher, A. & Wack, A. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat. Rev. Immunol. 23, 121\u2013133 (2023).","DOI":"10.1038\/s41577-022-00734-z"},{"key":"8407_CR15","doi-asserted-by":"publisher","first-page":"107813","DOI":"10.1016\/j.isci.2023.107813","volume":"26","author":"JA Hackney","year":"2023","unstructured":"Hackney, J. A. et al. A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling. iScience 26, 107813 (2023).","journal-title":"iScience"},{"key":"8407_CR16","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","volume":"182","author":"J Schulte-Schrepping","year":"2020","unstructured":"Schulte-Schrepping, J. et al. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell 182, 1419\u20131440.e23 (2020).","journal-title":"Cell"},{"key":"8407_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.cell.2022.01.012","volume":"185","author":"COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium","year":"2022","unstructured":"COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916\u2013938.e58 (2022).","journal-title":"Cell"},{"key":"8407_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41590-018-0111-5","volume":"19","author":"J Dunning","year":"2018","unstructured":"Dunning, J. et al. Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza. Nat. Immunol. 19, 625\u2013635 (2018).","journal-title":"Nat. Immunol."},{"key":"8407_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11249-y","volume":"10","author":"BM Tang","year":"2019","unstructured":"Tang, B. M. et al. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection. Nat. Commun. 10, 3422 (2019).","journal-title":"Nat. Commun."},{"key":"8407_CR20","doi-asserted-by":"publisher","first-page":"eabn5168","DOI":"10.1126\/scitranslmed.abn5168","volume":"14","author":"ST Chen","year":"2022","unstructured":"Chen, S. T. et al. A shift in lung macrophage composition is associated with COVID-19 severity and recovery. Sci. Transl. Med. 14, eabn5168 (2022).","journal-title":"Sci. Transl. Med."},{"key":"8407_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","volume":"26","author":"M Reyes","year":"2020","unstructured":"Reyes, M. et al. An immune-cell signature of bacterial sepsis. Nat. Med. 26, 333\u2013340 (2020).","journal-title":"Nat. Med."},{"key":"8407_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad, M., Blish, C. A., Sallusto, F. & Iwasaki, A. The immunology and immunopathology of COVID-19. Science 375, 1122\u20131127 (2022).","journal-title":"Science"},{"key":"8407_CR23","doi-asserted-by":"publisher","first-page":"eabe959","DOI":"10.1126\/scitranslmed.abe9599","volume":"13","author":"M Reyes","year":"2021","unstructured":"Reyes, M. et al. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro. Sci. Transl. Med. 13, eabe959 (2021).","journal-title":"Sci. Transl. Med."},{"key":"8407_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04868-5","volume":"28","author":"GGF Leite","year":"2024","unstructured":"Leite, G. G. F. et al. Monocyte state 1 (MS1) cells in critically ill patients with sepsis or non-infectious conditions: association with disease course and host response. Crit. Care 28, 88 (2024).","journal-title":"Crit. Care"},{"key":"8407_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41590-023-01490-5","volume":"24","author":"AJ Kwok","year":"2023","unstructured":"Kwok, A. J. et al. Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis. Nat. Immunol. 24, 767\u2013779 (2023).","journal-title":"Nat. Immunol."},{"key":"8407_CR26","doi-asserted-by":"publisher","first-page":"e20210582","DOI":"10.1084\/jem.20210582","volume":"218","author":"AJ Wilk","year":"2021","unstructured":"Wilk, A. J. et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J. Exp. Med. 218, e20210582 (2021).","journal-title":"J. Exp. Med."},{"key":"8407_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01576-3","author":"S Sinha","year":"2021","unstructured":"Sinha, S. et al. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-021-01576-3 (2021).","journal-title":"Nat. Med."},{"key":"8407_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/JLB.5MA0721-825R","volume":"110","author":"X Qiu","year":"2021","unstructured":"Qiu, X. et al. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis. J. Leukoc. Biol. 110, 1253\u20131268 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"8407_CR29","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913.e19 (2021).","journal-title":"Cell"},{"key":"8407_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"8407_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh2624","author":"MGP van der Wijst","year":"2021","unstructured":"van der Wijst, M. G. P. et al. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abh2624 (2021).","journal-title":"Sci. Transl. Med."},{"key":"8407_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-021-03234-7","volume":"591","author":"AJ Combes","year":"2021","unstructured":"Combes, A. J. et al. Global absence and targeting of protective immune states in severe COVID-19. Nature 591, 124\u2013130 (2021).","journal-title":"Nature"},{"key":"8407_CR33","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.cell.2021.02.018","volume":"184","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell 184, 1836\u20131857.e22 (2021).","journal-title":"Cell"},{"key":"8407_CR34","doi-asserted-by":"publisher","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","volume":"5","author":"JS Lee","year":"2020","unstructured":"Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554 (2020).","journal-title":"Sci. Immunol."},{"key":"8407_CR35","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210\u20131220 (2020).","journal-title":"Science"},{"key":"8407_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","journal-title":"Nat. Med."},{"key":"8407_CR37","doi-asserted-by":"publisher","first-page":"e135678","DOI":"10.1172\/jci.insight.135678","volume":"5","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y. et al. Single cell RNA sequencing identifies an early monocyte gene signature in acute respiratory distress syndrome. JCI Insight 5, e135678 (2020).","journal-title":"JCI Insight"},{"key":"8407_CR38","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.immuni.2020.11.017","volume":"53","author":"JP Bernardes","year":"2020","unstructured":"Bernardes, J. P. et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity 53, 1296\u20131314.e9 (2020).","journal-title":"Immunity"},{"key":"8407_CR39","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.celrep.2019.10.082","volume":"29","author":"AJ Hoogendijk","year":"2019","unstructured":"Hoogendijk, A. J. et al. Dynamic transcriptome-proteome correlation networks reveal human myeloid differentiation and neutrophil-specific programming. Cell Rep. 29, 2505\u20132519.e4 (2019).","journal-title":"Cell Rep."},{"key":"8407_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107597","volume":"26","author":"H Shivram","year":"2023","unstructured":"Shivram, H. et al. Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19. iScience 26, 107597 (2023).","journal-title":"iScience"},{"key":"8407_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1126\/science.2990035","volume":"229","author":"D Metcalf","year":"1985","unstructured":"Metcalf, D. The granulocyte-macrophage colony-stimulating factors. Science 229, 16\u201322 (1985).","journal-title":"Science"},{"key":"8407_CR42","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.smim.2021.101515","volume":"54","author":"HM Mehta","year":"2021","unstructured":"Mehta, H. M. & Corey, S. J. G-CSF, the guardian of granulopoiesis. Semin. Immunol. 54, 101515 (2021).","journal-title":"Semin. Immunol."},{"key":"8407_CR43","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202106-1514OC","author":"DE Leisman","year":"2021","unstructured":"Leisman, D. E. et al. Alveolar, endothelial, and organ injury marker dynamics in severe COVID-19. Am. J. Respir. Crit. Care Med. https:\/\/doi.org\/10.1164\/rccm.202106-1514OC (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"8407_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1164\/rccm.201501-0020OC","volume":"192","author":"M Jabaudon","year":"2015","unstructured":"Jabaudon, M. et al. Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 192, 191\u2013199 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"8407_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.immuni.2021.03.002","volume":"54","author":"H Zheng","year":"2021","unstructured":"Zheng, H. et al. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity 54, 753\u2013768.e5 (2021).","journal-title":"Immunity"},{"key":"8407_CR46","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1182\/bloodadvances.2022008834","volume":"7","author":"DJ Eddins","year":"2023","unstructured":"Eddins, D. J. et al. Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load. Blood Adv. 7, 778\u2013799 (2023).","journal-title":"Blood Adv."},{"key":"8407_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07321-6","volume":"22","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Interleukin-6 and granulocyte colony-stimulating factor as predictors of the prognosis of influenza-associated pneumonia. BMC Infect. Dis. 22, 343 (2022).","journal-title":"BMC Infect. Dis."},{"key":"8407_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24360-w","volume":"12","author":"L Vanderbeke","year":"2021","unstructured":"Vanderbeke, L. et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat. Commun. 12, 4117 (2021).","journal-title":"Nat. Commun."},{"key":"8407_CR49","doi-asserted-by":"publisher","first-page":"e20201129","DOI":"10.1084\/jem.20201129","volume":"217","author":"FP Veras","year":"2020","unstructured":"Veras, F. P. et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 217, e20201129 (2020).","journal-title":"J. Exp. Med."},{"key":"8407_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12931-023-02336-2","volume":"24","author":"FP Veras","year":"2023","unstructured":"Veras, F. P. et al. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respir. Res. 24, 66 (2023).","journal-title":"Respir. Res."},{"key":"8407_CR51","doi-asserted-by":"publisher","first-page":"e006589","DOI":"10.1136\/jitc-2022-006589","volume":"11","author":"V Cardot-Ruffino","year":"2023","unstructured":"Cardot-Ruffino, V. et al. G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. J. Immunother. Cancer 11, e006589 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"8407_CR52","doi-asserted-by":"publisher","first-page":"104346","DOI":"10.1016\/j.cellimm.2021.104346","volume":"364","author":"YS Lee","year":"2021","unstructured":"Lee, Y. S., Saxena, V., Bromberg, J. S. & Scalea, J. R. G-CSF promotes alloregulatory function of MDSCs through a c-Kit dependent mechanism. Cell. Immunol. 364, 104346 (2021).","journal-title":"Cell. Immunol."},{"key":"8407_CR53","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","volume":"384","author":"IO Rosas","year":"2021","unstructured":"Rosas, I. O. et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N. Engl. J. Med. 384, 1503\u20131516 (2021).","journal-title":"N. Engl. J. Med."},{"key":"8407_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1603-1","volume":"19","author":"M Stoeckius","year":"2018","unstructured":"Stoeckius, M. et al. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).","journal-title":"Genome Biol."},{"key":"8407_CR55","doi-asserted-by":"publisher","first-page":"e111640","DOI":"10.1371\/journal.pone.0111640","volume":"9","author":"LT Hoang","year":"2014","unstructured":"Hoang, L. T. et al. Patient-based transcriptome-wide analysis identify interferon and ubiquination pathways as potential predictors of influenza A disease severity. PLoS ONE 9, e111640 (2014).","journal-title":"PLoS ONE"},{"key":"8407_CR56","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1182\/blood-2006-02-002477","volume":"109","author":"O Ramilo","year":"2007","unstructured":"Ramilo, O. et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066\u20132077 (2007).","journal-title":"Blood"},{"key":"8407_CR57","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1164\/rccm.201602-0220OC","volume":"194","author":"WAA de Steenhuijsen Piters","year":"2016","unstructured":"de Steenhuijsen Piters, W. A. A. et al. Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med. 194, 1104\u20131115 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08407-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T20:33:05Z","timestamp":1757277185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08407-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8407"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08407-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are employees of Genentech, Inc. at the time of this study and own equity in Roche.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1096"}}